1920 Terry Ave
5 articles with Umoja Biopharma
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
10/22/2021Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Umoja Biopharma, an oncology company leveraging its proprietary integrated technologies to reprogram immune cells in vivo to create next-generation immunotherapies for the treatment of solid tumors and hematologic malignancies, announced the appointment of Clay Siegall, Ph.D. as its Chairman of the Board of Directors.
The 146,000 square foot facility will benefit Umoja Biopharma to eliminate crucial CAR-T production barriers. There’s a lot more going on, know everything here.
Immunotherapies are about to get safer, more effective, and even more accessible with the new biotech’s novel approach.